The Relationship between Plasma Endothelin-1, Nitric Oxide Levels, and Heart Rate Variability in Patients with Coronary Slow Flow

Annals of Noninvasive Electrocardiology

Volumn 9, Issue 1, 2004, Pages 24-33

  Pekdemir, Hasan ^a,b   Cicek, Dilek ^a   Camsari, Ahmet ^a   Akkus, M Necdet ^a   Cin, V Gokhan ^a   Doven, Oben ^a   Parmaksiz, H Tuncay ^a   Katircibasi, M Tuna ^a   Ozcan, I Turkay ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Atherosclerosis; Coronary slow flow; Endothelin 1; Heart rate variability; Nitric oxide

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTERY INTIMA; ARTERY OCCLUSION; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; DISSEMINATED INTRAVASCULAR CLOTTING; EXERCISE TEST; FEMALE; HEART MUSCLE BLOOD FLOW; HEART RATE VARIABILITY; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; TIME;

ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; REGIONAL BLOOD FLOW;

EID: 1242315514     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2004.91522.x     Document Type: Article

References (41)

1. Tambe AA, Demany MA, Zimmerman HA, et al. Angina pectoris and slow flow velocity of dye in coronary arteries: A new angiographic finding. Am Heart J 1972;84:66-71.
2. Mosseri M, Yarom R, Gotsman MS, et al. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964-972.
3. Mangieri E, Macchiarelli G, Ciavolella M, et al. Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diag 1996;37:375-381.
4. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001;87:777-779.
5. Sezgin AT, Sigirci A, Barutcu I. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003;14:155-161.
6. Highsmith RF, Blackburn K, Schmidt DJ. Endothelin and calcium dynamics in vascular smooth muscle. Annu Rev Physiol 1992;54:257-277.
7. Egashira K, Katsuda Y, Mohri M, et al. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circulation Research 1996;79:331-335.
8. Buus NH, Bottcher M, Bottker HE, et al. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. Am J Cardiol 1999;83:149-154.
9. Kaski JC, Cox ID, Crook JR, et al., for the Coronary Artery Disease Research Group. Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries.. Am Heart J 1998;136:412-417.
10. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065.
11. Quintana M, Storck N, Lindblad LE, et al. Heart rate variability as a means of assessing prognosis after acute myocardial infarction. Eur Heart J 1997;18:789-797.
12. Huikuri HV, Jokinen V, Syvanne M, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1979-1985.
13. Rosano GMC, Ponikowski P, Adamopoulos S, et al. Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 1994;73:1174-1179.
14. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
15. Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults evidence from intravascular ultrasound. Circulation 2001;103:2705-2710.
16. Kleiger RE, Stein PK, Bosner MS, et al. Time domain measurements of heart rate variability. Cardiol Clin 1992;10:487-498.
17. James TN. Small arteries of the heart. Circulation 1977;56:2-14.
18. Ratcliffe HL, Redfield E. Atherosclerotic stenosis of the extramural and intramural coronary arteries of man. Related lesions. Virchows Arch A Pathol Pathol Anat 1972;357:1-10.
19. Chilian WM, Dellsperger KC, Layne SM, et al. Effects of atherosclerosis on the coronary microcirculation. Am J Physiol 1990;258:H529-H539.
20. Zeiher AM, Schachinger V, Hohnloser SH, et al. Coronary atherosclerotic wall thickening and vascular reactivity in humans: Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 1994;89:2525-2532.
21. Nakatani S, Yamagishi M, Tamai J, et al. Assessment of coronary artery distensibility by intravascular ultrasound application of simultaneous measurements of luminal area and pressure. Circulation 1995;91:2904-2910.
22. Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: An intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-1485.
23. Kaplan JR, Manuck SB, Adams MR, et al. Inhibition of coronary atherosclerosis by propranolol on behaviorally predisposed monkeys fed an atherogenic diet. Circulation 1987;86:1364-1372.
24. Kaplan JR, Manuck SB, Clarkson TB. The influence of heart rate on coronary atherosclerosis. J Cardiovasc Pharm 1987;10(Suppl. 2):S100-S102.
25. Sa Cunha R, Pannier B, Benetos A, et al. Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertension 1997;15:1423-1430.
26. Yu SM, Tsai SY, Guh JH, et al. Mechanisms of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation 1996;94:547-4.
27. Dzau VJ, Sarbs FM. Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol 1987;10(Suppl. 9):S2-S6.
28. Duru F, Barton M, Luscher TF, et al. Endothelin and cardiac arrhythmias: Do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc Res 2001;49:272-280.
29. Ihling C, Szombathy T, Bohrmann B, et al. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 2001;104:864-869.
30. Meeder JG, Blanksma PK, Crijns HGJM, et al. Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J 1995;16:1571-1577.
31. Papadakis MC, Manginas A, Cotileas P, et al. Documentation of slow coronary flow by the TIMI frame count in patients with coronary ectasia. Am J Cardiol 2001;88:1030-1032.
32. Kawada T, Sugimachi M, Shishido T, et al. Simultaneous identification of static and dynamic vagosympathetic interactions in regulating heart rate. Am J Physiol 1999;276:R782-R789.
33. Rosen SD, Dritsas A, Bourdillon PJ, et al. Analysis of the electrocardiographic QT interval in patients with syndrome X. Am J Cardiol 1994;73:971-972.
34. Adamopoulos S, Rosano GMC, Ponikowski P, et al. Impaired baroreflex sensitivity and sympathovagal balance in syndrome X. Am J Cardiol 1998;82:862-868.
35. Leonardo F, Fragasso G, Rosano GMC, et al. Effect of atenolol on QT interval and dispersion in patients with syndrome X. Am J Cardiol 1994;73:1174-1179.
36. Feigl EO. Adrenergic control of transmural coronary blood flow. Basic Res Cardiol 1990;85(Suppl. I):167-176.
37. Zehier AM, Drexler H, Wollschlaeger H, et al. Coronary vasomotion in response to sympathetic stimulation in humans: Importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989;14:1181-1190.
38. Cordero DL, Cagin NA, Natelson BH. Neurocardiology update: Role of the nervous system in coronary vasomotion. Cardiovasc Res 1995;29:319-328.
39. Aronson D, Mittleman MA, Burger AJ. Role of endothelin in modulation of heart rate variability in patients with decompensated heart failure. Pacing Clin Electrophysiol 2001;24:1607-1615.
40. Ponikowski P, Rosano GM, Amadi AA, et al. Transient autonomic dysfunction precedes ST-segment depression in patients with syndrome X. Am J Cardiol 1996;77:942-947.
41. Gould KL, Nakagawa Y, Nakagawa K, et al. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography. Circulation 2000;101:1931-1939.